Dr. Orin Bloch is the Director of Neurosurgical Oncology at the UC Davis Comprehensive Cancer Center and an Associate Professor of Neurological Surgery at the University of California, Davis School of Medicine. He is a board-certified neurosurgeon, scientist, and internationally recognized expert in the management of patients with brain tumors. His comprehensive approach to patients with benign and malignant tumors of the brain and skull base comes from years of clinical experience and research. He performs over 250 brain tumor operations annually and oversees a multidisciplinary clinical and research program for brain tumor treatment. He is the principal investigator of an NIH-funded Brain Tumor Immunotherapy Laboratory and the team leader for multiple brain tumor clinical trials.
Dr. Bloch’s research is focused on innovative new medical and surgical therapies for the treatment of primary and metastatic cancer of the brain. His laboratory studies mechanisms of immune resistance in patients with cancer to identify new targets to enhance brain tumor immunotherapy. He is a leader in the development of new technologies for brain tumor surgery, including advances in stereotactic image-guided navigation, fluorescence microscopy, and minimally-invasive laser ablation. Dr. Bloch is the leader of the Brain Tumor Innovations group and the co-director of the Biomedical Technology Program at the UC Davis Comprehensive Cancer Center.